Drug Information

Drug General Information
Drug ID
D0T7YM
Former ID
DNC007076
Drug Name
Oleic acid anilide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528385]
Formula
C24H39NO
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)NC1=CC=CC=C1
InChI
1S/C24H39NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-24(26)25-23-20-17-16-18-21-23/h9-10,16-18,20-21H,2-8,11-15,19,22H2,1H3,(H,25,26)/b10-9-
InChIKey
YPUOCYKJOLQYQS-KTKRTIGZSA-N
PubChem Compound ID
5354590
Target and Pathway
Target(s) Liver carboxylesterase Target Info Inhibitor [528217]
mRNA of human acyl CoA cholesterol acyl-transferase-2 Target Info Inhibitor [528385]
KEGG Pathway Drug metabolism - other enzymes
Metabolic pathwayshsa00100:Steroid biosynthesis
PANTHER Pathway Androgen/estrogene/progesterone biosynthesis
Pathway Interaction Database E2F transcription factor network
WikiPathways NRF2 pathway
Nuclear Receptors Meta-Pathway
Heroin metabolism
Irinotecan Pathway
Fluoropyrimidine Activity
Phase I biotransformations, non P450
References
Ref 528385Bioorg Med Chem Lett. 2006 Nov 1;16(21):5580-3. Epub 2006 Aug 21.Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata.
Ref 528217J Nat Prod. 2006 May;69(5):853-5.Phenolic compounds from the roots of Lindera fruticosa.
Ref 528385Bioorg Med Chem Lett. 2006 Nov 1;16(21):5580-3. Epub 2006 Aug 21.Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata.